In breast cancer, CREB3 was identified as a transcriptional regulator of enhanced ADP ribosylation factor 4, COPI coat complex subunit beta 1, and USO1 vesicle transport factor, leading to promotion of endoplasmic reticulum (ER)‐Golgi trafficking and acceleration of tumor cells metastasis.15 Here, CREB3 is linked to breast cancer.